ASBMT statement on routine prophylaxis for central nervous system recurrence of acute lymphoblastic leukemia following allogeneic hematopoietic cell transplantation Review


Authors: Sauter, C. S.; DeFilipp, Z.; Inamoto, Y.; Johnston, L.; Nagler, A.; Savani, B. N.; Carpenter, P. A.; Perales, M. A.
Review Title: ASBMT statement on routine prophylaxis for central nervous system recurrence of acute lymphoblastic leukemia following allogeneic hematopoietic cell transplantation
Abstract: Hematologic malignancies treated with allogeneic hematopoietic cell transplantation (allo-HCT) have a variable incidence of post-transplantation central nervous system (CNS) relapse, with acute lymphoblastic leukemia (ALL) representing the most common disease histology. Although data supporting post-transplantation CNS prophylaxis for ALL in the pre-CNS penetrant systemic therapy era established this as standard practice, controversy exists regarding the role of post-transplantation CNS prophylaxis in the contemporary era. Here we review the most relevant (albeit exclusively retrospective) literature to date on the role of post-transplantation CNS prophylaxis in ALL. Given the paucity of data supporting the routine practice of post-transplantation CNS prophylaxis for ALL in the contemporary era, this position statement is anticipated to further stoke controversy and discussion within the transplantation community. Ultimately, only well-designed prospective clinical studies will elucidate the role of routine post-transplantation CNS prophylaxis. © 2019 American Society for Blood and Marrow Transplantation
Keywords: cancer recurrence; editorial; practice guideline; cancer therapy; acute lymphoblastic leukemia; central nervous system; prophylaxis; allogeneic hematopoietic stem cell transplantation; induction chemotherapy; acute lymphoblastic lymphoma; central nervous system prophylaxis; human
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 25
Issue: 3
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2019-03-01
Start Page: e86
End Page: e88
Language: English
DOI: 10.1016/j.bbmt.2018.12.757
PUBMED: 30590125
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Steven Sauter
    334 Sauter
  2. Miguel-Angel Perales
    918 Perales